NYSE - Delayed Quote USD

Prestige Consumer Healthcare Inc. (PBH)

70.47

+0.33

(+0.47%)

At close: April 26 at 4:00 PM EDT

70.47

0.00

(0.00%)

After hours: April 26 at 5:59 PM EDT

Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 days ago

PBH
+0.47%
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close. The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m. ET. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.pre

GlobeNewswire 2 days ago

PBH
+0.47%
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 19 days ago

PBH
+0.47%
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bagsTARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief,

GlobeNewswire 24 days ago

PBH
+0.47%
Is Prestige Consumer Healthcare Inc. (NYSE:PBH) Trading At A 49% Discount?

Key Insights The projected fair value for Prestige Consumer Healthcare is US$143 based on 2 Stage Free Cash Flow to...

Simply Wall St. last month

PBH
+0.47%
Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks last month

PBH
+0.47%
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 2 months ago

PBH
+0.47%
Insider Sell: CFO Christine Sacco Sells 30,019 Shares of Prestige Consumer Healthcare Inc (PBH)

Prestige Consumer Healthcare Inc (NYSE:PBH), a company that markets and distributes over-the-counter healthcare and household cleaning products, has reported an insider sell according to a recent SEC filing.

GuruFocus.com 2 months ago

PBH
+0.47%
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Shareholders of Prestige Consumer Healthcare Inc. ( NYSE:PBH ) will be pleased this week, given that the stock price is...

Simply Wall St. 2 months ago

PBH
+0.47%
Prestige Consumer Healthcare Third Quarter 2024 Earnings: EPS Beats Expectations

Prestige Consumer Healthcare ( NYSE:PBH ) Third Quarter 2024 Results Key Financial Results Revenue: US$282.7m (up 2.6...

Simply Wall St. 2 months ago

PBH
+0.47%
Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024

Company Raises Full-Year Fiscal 2024 Earnings Outlook

GuruFocus.com 2 months ago

PBH
+0.47%
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings Outlook to Approximately $4.33 TARRYTOWN, N.Y., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2023. “We are pleased with our continued strong results that exceeded our revenue

GlobeNewswire 2 months ago

PBH
+0.47%
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product co

GlobeNewswire 2 months ago

PBH
+0.47%
Prestige Consumer Healthcare (PBH) Reports Next Week: What Awaits?

Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 months ago

PBH
+0.47%
Verano Holdings Corp. (VRNOF) Surges 6.5%: Is This an Indication of Further Gains?

Verano Holdings Corp. (VRNOF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 3 months ago

PBH
+0.47%
VRNOF
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday, February 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. T

GlobeNewswire 3 months ago

PBH
+0.47%
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Americaine® 20% Benzocaine Topical Anesthetic Spray Americaine® 20% Benzocaine Topical Anesthetic Spray TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray to the consumer level. While benzene is not an ingredient in any Americaine® 20% Benzocaine Topical Anesthetic Spray products, a recent review by our manufacturer and their th

GlobeNewswire 4 months ago

PBH
+0.47%
Should You Invest in Prestige Consumer Healthcare (PBH)?

Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The third quarter saw losses in the U.S. stock market due to concerns about a government shutdown, autoworker strikes, rising oil prices, and the possibility that interest rates might stay higher for longer. […]

Insider Monkey 4 months ago

PBH
+0.47%
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from tw

GlobeNewswire 5 months ago

PBH
+0.47%
Prestige Consumer Healthcare's (NYSE:PBH) investors will be pleased with their respectable 70% return over the last three years

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

Simply Wall St. 5 months ago

PBH
+0.47%

Performance Overview

Return	PBH	S&P 500
YTD	+15.11%	+6.92%
1-Year	+14.70%	+25.26%
3-Year	+57.26%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Prestige Consumer Healthcare Inc. (PBH)

Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Is Prestige Consumer Healthcare Inc. (NYSE:PBH) Trading At A 49% Discount?

Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Insider Sell: CFO Christine Sacco Sells 30,019 Shares of Prestige Consumer Healthcare Inc (PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Prestige Consumer Healthcare Third Quarter 2024 Earnings: EPS Beats Expectations

Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Prestige Consumer Healthcare (PBH) Reports Next Week: What Awaits?

Verano Holdings Corp. (VRNOF) Surges 6.5%: Is This an Indication of Further Gains?

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Should You Invest in Prestige Consumer Healthcare (PBH)?

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Prestige Consumer Healthcare's (NYSE:PBH) investors will be pleased with their respectable 70% return over the last three years

Performance Overview